These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17014950)

  • 41. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.
    Imamura M; Abrams P; Bain C; Buckley B; Cardozo L; Cody J; Cook J; Eustice S; Glazener C; Grant A; Hay-Smith J; Hislop J; Jenkinson D; Kilonzo M; Nabi G; N'Dow J; Pickard R; Ternent L; Wallace S; Wardle J; Zhu S; Vale L
    Health Technol Assess; 2010 Aug; 14(40):1-188, iii-iv. PubMed ID: 20738930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
    Rabasseda X
    Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A challenge].
    Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
    [No Abstract]   [Full Text] [Related]  

  • 45. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New options in pharmacological treatment of urinary stress incontinence in women].
    Martan A
    Ceska Gynekol; 2004 Nov; 69(6):500-6. PubMed ID: 15633423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacologic treatment of stress urinary incontinence: expectations for outcome.
    Schuessler B; Baessler K
    Urology; 2003 Oct; 62(4 Suppl 1):31-8. PubMed ID: 14550835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Update on medical treatment of female stress urinary incontinence].
    Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
    Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence].
    Krankenpfl J; 2005; 43(7-10):189-90. PubMed ID: 16515261
    [No Abstract]   [Full Text] [Related]  

  • 50. How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany.
    Manning M; Gotsch U; Minarzyk A; Quail D; Gross A; Pages I; Methfessel HD; Michel MC
    Int J Clin Pract; 2009 Dec; 63(12):1724-33. PubMed ID: 19930333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mixed incontinence.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2055-7. PubMed ID: 15879826
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
    Puyol M; Collado A
    Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
    Cardozo L
    J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New developments in the treatment of urinary incontinence.
    Vella M; Robinson D; Cardozo L; Cartwright R
    Minerva Urol Nefrol; 2006 Dec; 58(4):299-310. PubMed ID: 17268395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.
    Baessler K; Christmann-Schmid C; Maher C; Haya N; Crawford TJ; Brown J
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013108. PubMed ID: 30121956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term efficacy of duloxetine in women with stress urinary incontinence.
    Bump RC; Voss S; Beardsworth A; Manning M; Zhao YD; Chen W
    BJU Int; 2008 Jul; 102(2):214-8. PubMed ID: 18422764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of duloxetine on quality of life for women with symptoms of urinary incontinence.
    Kinchen KS; Obenchain R; Swindle R
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(5):337-44. PubMed ID: 15662490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.